{"nctId":"NCT00038948","briefTitle":"Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant Recipients","startDateStruct":{"date":"2002-01"},"conditions":["Renal Transplantation"],"count":830,"armGroups":[{"label":"A","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Sirolimus","Drug: tacrolimus","Drug: Cyclosporine A"]},{"label":"B","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Sirolimus","Drug: tacrolimus","Drug: Cyclosporine A"]}],"interventions":[{"name":"Sirolimus","otherNames":[]},{"name":"tacrolimus","otherNames":[]},{"name":"Cyclosporine A","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age greater than or equal to 13 years.\n* Receiving CsA or tacrolimus from the time of transplantation or within 2 weeks thereafter\n* Patients with a functioning allograft and a Nankivell GFR greater than or equal to 20 mL/min, within 2 weeks before randomization\n\nExclusion Criteria:\n\n* Biopsy-confirmed acute rejection within 12 weeks before randomization, that was determined to require antirejection treatment\n* Patients in whom kidney-pancreas or other multiple organ transplants have been performed","healthyVolunteers":false,"sex":"ALL","minimumAge":"13 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Nankivell Glomerular Filtration Rate (GFR)","description":"Nankivell GFR: patients with baseline GFR of 20.0 to 40.0 mL/min and patients with baseline GFR of greater than 40.0 mL/min. GFR is an index of kidney function. A higher value means better kidney function.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24.56","spread":"2.42"},{"groupId":"OG001","value":"27.24","spread":"3.71"},{"groupId":"OG002","value":"59.04","spread":"0.89"},{"groupId":"OG003","value":"57.73","spread":"1.1"}]}]}]},{"type":"SECONDARY","title":"First Occurrence of Biopsy-confirmed Acute Rejection, Graft Loss, or Death.","description":"Number of patients who experienced for the first time either biopsy-confirmed acute rejection, graft loss, or death by weeks 52 and 104. Assessed by individual endpoint and as composite endpoint (all combined).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"8","spread":null},{"groupId":"OG003","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"3","spread":null},{"groupId":"OG002","value":"3","spread":null},{"groupId":"OG003","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"6","spread":null},{"groupId":"OG003","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"5","spread":null},{"groupId":"OG003","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"27","spread":null},{"groupId":"OG003","value":"9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"9","spread":null},{"groupId":"OG002","value":"12","spread":null},{"groupId":"OG003","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"13","spread":null},{"groupId":"OG003","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"2","spread":null},{"groupId":"OG002","value":"13","spread":null},{"groupId":"OG003","value":"8","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":81,"n":551},"commonTop":["Hyperlipemia","Diarrhea","Hypercholesteremia","Anemia","Infection"]}}}